CountryOfPapers CountryOfPapers
Journal list Promote Sponsor
verified SJR 2,29 · Q1 • database Scopus / SJR & Web of Science indexed
BioDrugs
Switzerland
workspace_premium Q1 — Medicine (miscellaneous) lock Subscription

BioDrugs

BioDrugs is a journal indexed in SJR in Medicine (miscellaneous) and Biotechnology with an H index of 84. It has a price of 3580 €. It has an SJR impact factor of 2,29 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,29.

BioDrugs focuses its scope in these topics and keywords: treatment, bevacizumab, biosimilar, randomized, review, cancer, previously, efficacy, lymphoma, patients, ...

ISSN: 1173-8804
Category: Medicine (miscellaneous)
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
2,29 Q1
H-index 84
Acceptance rate pie_chart
27% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
3.580 € Subscription
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

2,29

H-index

84

Docs (year)

57

Docs 3y

166

Total refs

4439

Cites 3y

1115

Citable 3y

160

Cites/Doc 2y

6.96

Ref/Doc

77.88

Immediate OA

3580 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs

What is the SJR of BioDrugs?

BioDrugs has an SJR of 2,29 (best quartile Q1) in the CountryOfPapers database.

What is the APC / publication cost?

Immediate OA APC is 3580 EUR. Non-OA / submission fee is 0 EUR.

What is the acceptance rate?

The acceptance rate recorded for BioDrugs is 27%.